vs

Side-by-side financial comparison of HOME BANCSHARES INC (HOMB) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

HOME BANCSHARES INC is the larger business by last-quarter revenue ($282.1M vs $37.2M, roughly 7.6× Organogenesis Holdings Inc.). On growth, HOME BANCSHARES INC posted the faster year-over-year revenue change (9.2% vs -57.1%). Over the past eight quarters, HOME BANCSHARES INC's revenue compounded faster (7.0% CAGR vs -46.5%).

Home BancShares, Inc., operating as Centennial Bank, is a bank holding company based in Conway, Arkansas. It is on the list of largest banks in the United States. The bank operates 222 branches in Arkansas, Alabama, Florida,Texas, and New York City.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

HOMB vs ORGO — Head-to-Head

Bigger by revenue
HOMB
HOMB
7.6× larger
HOMB
$282.1M
$37.2M
ORGO
Growing faster (revenue YoY)
HOMB
HOMB
+66.2% gap
HOMB
9.2%
-57.1%
ORGO
Faster 2-yr revenue CAGR
HOMB
HOMB
Annualised
HOMB
7.0%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HOMB
HOMB
ORGO
ORGO
Revenue
$282.1M
$37.2M
Net Profit
$118.2M
Gross Margin
30.8%
Operating Margin
54.4%
-185.1%
Net Margin
41.9%
Revenue YoY
9.2%
-57.1%
Net Profit YoY
17.6%
EPS (diluted)
$0.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HOMB
HOMB
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$282.1M
$225.6M
Q3 25
$277.7M
$150.9M
Q2 25
$271.0M
$101.0M
Q1 25
$260.1M
$86.7M
Q4 24
$258.4M
$126.7M
Q3 24
$258.0M
$115.2M
Q2 24
$254.6M
$130.2M
Net Profit
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
$118.2M
$43.7M
Q3 25
$123.6M
$21.6M
Q2 25
$118.4M
$-9.4M
Q1 25
$115.2M
$-18.8M
Q4 24
$100.6M
$7.7M
Q3 24
$100.0M
$12.3M
Q2 24
$101.5M
$-17.0M
Gross Margin
HOMB
HOMB
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
HOMB
HOMB
ORGO
ORGO
Q1 26
-185.1%
Q4 25
54.4%
28.1%
Q3 25
57.4%
13.7%
Q2 25
56.1%
-12.5%
Q1 25
56.6%
-30.9%
Q4 24
50.1%
8.1%
Q3 24
50.0%
5.4%
Q2 24
52.4%
-10.7%
Net Margin
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
41.9%
19.4%
Q3 25
44.5%
14.3%
Q2 25
43.7%
-9.3%
Q1 25
44.3%
-21.7%
Q4 24
38.9%
6.1%
Q3 24
38.8%
10.7%
Q2 24
39.9%
-13.1%
EPS (diluted)
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
$0.60
$0.31
Q3 25
$0.63
$0.11
Q2 25
$0.60
$-0.10
Q1 25
$0.58
$-0.17
Q4 24
$0.50
$0.05
Q3 24
$0.50
$0.09
Q2 24
$0.51
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HOMB
HOMB
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$667.3M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.3B
Total Assets
$22.9B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HOMB
HOMB
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$667.3M
$93.7M
Q3 25
$800.9M
$63.7M
Q2 25
$1.1B
$73.1M
Q1 25
$1.3B
$110.0M
Q4 24
$910.3M
$135.6M
Q3 24
$1.0B
$94.3M
Q2 24
$1.1B
$89.9M
Total Debt
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
$4.3B
$300.1M
Q3 25
$4.2B
$255.1M
Q2 25
$4.1B
$233.2M
Q1 25
$4.0B
$242.9M
Q4 24
$4.0B
$262.9M
Q3 24
$4.0B
$278.5M
Q2 24
$3.9B
$263.5M
Total Assets
HOMB
HOMB
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$22.9B
$598.7M
Q3 25
$22.7B
$509.8M
Q2 25
$22.9B
$461.1M
Q1 25
$23.0B
$467.4M
Q4 24
$22.5B
$497.9M
Q3 24
$22.8B
$446.3M
Q2 24
$22.9B
$443.2M
Debt / Equity
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HOMB
HOMB
ORGO
ORGO
Operating Cash FlowLast quarter
$399.3M
Free Cash FlowOCF − Capex
$377.0M
FCF MarginFCF / Revenue
133.7%
Capex IntensityCapex / Revenue
7.9%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$669.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
$399.3M
$39.4M
Q3 25
$115.2M
$3.1M
Q2 25
$78.4M
$-32.9M
Q1 25
$117.0M
$-19.9M
Q4 24
$460.6M
$10.9M
Q3 24
$128.6M
$8.7M
Q2 24
$109.4M
$4.7M
Free Cash Flow
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
$377.0M
$34.8M
Q3 25
$112.2M
$844.0K
Q2 25
$70.4M
$-36.5M
Q1 25
$110.1M
$-23.6M
Q4 24
$422.1M
$7.6M
Q3 24
$116.2M
$6.1M
Q2 24
$99.2M
$2.9M
FCF Margin
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
133.7%
15.4%
Q3 25
40.4%
0.6%
Q2 25
26.0%
-36.1%
Q1 25
42.3%
-27.2%
Q4 24
163.4%
6.0%
Q3 24
45.1%
5.3%
Q2 24
38.9%
2.2%
Capex Intensity
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
7.9%
2.1%
Q3 25
1.0%
1.5%
Q2 25
3.0%
3.6%
Q1 25
2.6%
4.2%
Q4 24
14.9%
2.7%
Q3 24
4.8%
2.2%
Q2 24
4.0%
1.4%
Cash Conversion
HOMB
HOMB
ORGO
ORGO
Q1 26
Q4 25
3.38×
0.90×
Q3 25
0.93×
0.14×
Q2 25
0.66×
Q1 25
1.02×
Q4 24
4.58×
1.43×
Q3 24
1.29×
0.71×
Q2 24
1.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons